Published March 2021 | Version v1
Journal article

Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series

  • 1. Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University (China)
  • 2. Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou (China)
  • 3. Department of Radiation Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou (China)
  • 4. Department of Radiation Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou (China)

Description

Highlights: • "Modified reduced-volume IMRT" was re-defined based on our previous reported technique "reduced-volume IMRT". • "Modified reduced-volume IMRT" omitted CTV1 and narrowed the margin of CTV2. • This de-intensification technique was feasible and did not compromise therapeutic efficacy. • This renew technique simplified the procedures of target contouring and optimization of RT plan. Although the efficacy of "reduced-volume intensity-modulated radiation therapy (IMRT)" in nasopharyngeal carcinoma (NPC) has been confirmed, two issues regarding the necessity of clinical target volume 1(CTV1) delineation and the optimal margin of CTV2 remained undetermined. The current series, utilized de-intensification technique that omitted the contouring of CTV1 and narrowed the margin of CTV2 from 10 mm to 8 mm, namely "modified reduced-volume IMRT" was initiated to evaluate the efficacy and feasibility of this renew technique in a prospective series.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2020.12.035

Additional details

Identifiers

DOI
10.1016/j.radonc.2020.12.035;
PII
S0167814020312627;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
156
Journal Page Range
p. 251-257
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54013905
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; METASTASES; OPTIMIZATION; RADIOTHERAPY
Descriptors DEC
DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.